Controlled clinical trials

Results: 355



#Item
291J Vet Intern Med 2010;24:57–64  Note from the editor: The REFLECT statement is also published in Journal of Food Protection, Zoonoses and Public Health, and Journal of Swine Health and Production. The Editorial board o

J Vet Intern Med 2010;24:57–64 Note from the editor: The REFLECT statement is also published in Journal of Food Protection, Zoonoses and Public Health, and Journal of Swine Health and Production. The Editorial board o

Add to Reading List

Source URL: www.reflect-statement.org

Language: English - Date: 2010-03-17 13:14:24
292132 Journal of Food Protection, Vol. 73, No. 1, 2010, Pages 132–139 Review  The REFLECT Statement: Methods and Processes of Creating

132 Journal of Food Protection, Vol. 73, No. 1, 2010, Pages 132–139 Review The REFLECT Statement: Methods and Processes of Creating

Add to Reading List

Source URL: www.reflect-statement.org

Language: English - Date: 2010-03-17 13:14:24
293doi:[removed]j.prevetmed[removed]

doi:[removed]j.prevetmed[removed]

Add to Reading List

Source URL: www.reflect-statement.org

Language: English - Date: 2010-03-17 13:14:24
294Zoonoses and Public Health  ORIGINAL ARTICLE The REFLECT Statement: Methods and Processes of Creating Reporting Guidelines for Randomized Controlled Trials for

Zoonoses and Public Health ORIGINAL ARTICLE The REFLECT Statement: Methods and Processes of Creating Reporting Guidelines for Randomized Controlled Trials for

Add to Reading List

Source URL: www.reflect-statement.org

Language: English - Date: 2010-03-17 13:14:24
295Zoonoses and Public Health  ORIGINAL ARTICLE The REFLECT Statement: Reporting Guidelines for Randomized Controlled Trials in Livestock and Food Safety:

Zoonoses and Public Health ORIGINAL ARTICLE The REFLECT Statement: Reporting Guidelines for Randomized Controlled Trials in Livestock and Food Safety:

Add to Reading List

Source URL: www.reflect-statement.org

Language: English - Date: 2010-03-17 13:14:24
296Surrogate Endpoints Mark Rothmann* Minimal Residue Disease in CLL Workshop February 27, 2013 *The views expressed in this presentation are those of the presenters and do not necessarily represent those of the U.S. Food a

Surrogate Endpoints Mark Rothmann* Minimal Residue Disease in CLL Workshop February 27, 2013 *The views expressed in this presentation are those of the presenters and do not necessarily represent those of the U.S. Food a

Add to Reading List

Source URL: www.fda.gov

Language: English
297Meta-Analysis of Randomized Controlled Clinical Trials for Safety Evaluation

Meta-Analysis of Randomized Controlled Clinical Trials for Safety Evaluation

Add to Reading List

Source URL: www.fda.gov

Language: English
298 COMMENTARY   Improving the Reporting Quality of Nonrandomized Evaluations of Behavioral and Public Health Interventions: The TREND Statement Developing an evidence base

 COMMENTARY  Improving the Reporting Quality of Nonrandomized Evaluations of Behavioral and Public Health Interventions: The TREND Statement Developing an evidence base

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2009-11-02 15:03:26
299Statistical Considerations for Surrogate Endpoints Mark Rothmann* Minimal Residue Disease in AML Workshop March 4, 2013 *The views expressed in this presentation are those of the presenters and

Statistical Considerations for Surrogate Endpoints Mark Rothmann* Minimal Residue Disease in AML Workshop March 4, 2013 *The views expressed in this presentation are those of the presenters and

Add to Reading List

Source URL: www.fda.gov

Language: English
300Session 1: Complex Issues for Trial Design: Endpoints Public Workshop on the Complex Issues in Developing Drug and Biological Products for Rare Diseases January 6 & 7, 2014

Session 1: Complex Issues for Trial Design: Endpoints Public Workshop on the Complex Issues in Developing Drug and Biological Products for Rare Diseases January 6 & 7, 2014

Add to Reading List

Source URL: www.fda.gov

Language: English